Table 1.
Values of the analytical parameters assessed
| Exam | Patient result | Reference value |
| Hemoglobin | 13.2 g/dL | 12.0–16.0 g/dL |
| Platelets | 249 × 109/L | 150–400 × 109/L |
| Leukocytes | 6.45 × 109/L | 4.00–11.00 × 109/L |
| Creatinine | 0.49 mg/dL | 0.51–0.95 mg/dL |
| Sodium | 141 mEq/L | 135–147 mEq/L |
| Potassium | 4.3 mEq/L | 3.5–5.1 mEq/L |
| Chlorides | 104 mEq/L | 101–109 mEq/L |
| Angiotensin-Converting Enzyme | 49 U/L | 20–70 U/L |
| Lysozyme | 30.0 mg/L | 4.0–13.0 mg/L |
| Antiherpes virus I IgG | Positive | — |
| Antiherpes virus I IgM | Negative | — |
| Antiherpes virus II IgG | Negative | — |
| Antiherpes virus II IgM | Positive | — |
| Antitoxoplasma IgG | Positive | — |
| Antitoxoplasma IgM | Negative | — |
| HIV (1 and 2) | Negative | — |
| CLIA Antitreponema IgG | Reactive | — |
| VDRL | Positive—512 Dilutions | — |
| CSF Cytology | 13 cells, 300 erythrocytes | <5 cells |
| CSF Total Proteins | 0.41 g/L | 0.15–0.45 g/L |
| CSF Glucose | 57 mg/dL | 60–70% serum Glucose |
| CSF Western blot TP IgG | Positive | — |
| CSF VDRL | Positive—2 Dilutions | — |
| CSF DNA Treponema pallidum | Negative | — |
| CSF Bacteriology | Negative | — |
CLIA = chemiluminescent immunoassay; CSF = cerebrospinal fluid; IgG = immunoglobulin G; IgM = immunoglobulin M; TP = Treponema pallidum; VDRL = veneral disease research laboratory.